Integrated care for older adults with atrial fibrillation
Part of Brain & nervous system, Heart & circulation, Hormones & metabolism, Lungs & breathing clinical trials.
This trial is testing a new approach to care for older adults with atrial fibrillation (an irregular heartbeat) who also have other health conditions. It aims to see if a more integrated, team-based care plan helps improve their overall health and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older.
- You have atrial fibrillation (an irregular heartbeat), confirmed by a doctor.
- You have at least one other long-term health condition, like high blood pressure, heart disease, or diabetes.
- You do not have a mechanical heart valve or severe mitral valve narrowing.
- You are willing to participate and attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing if an AI program can help doctors choose better treatments for atrial fibrillation (AF). It is for people who were recently diagnosed with AF and have noticeable symptoms.
This study looks at people who are at high risk for atrial fibrillation (an irregular heartbeat) to understand their risk of stroke and blood clots. You may be able to join if you are 65-95 years old, have no prior atrial fibrillation, and can use a smartphone.
This trial compares a procedure called catheter ablation (which uses heat to destroy tiny areas of heart tissue causing irregular rhythms) with usual medical care in adults aged 78 and older who have atrial fibrillation (AFib). The goal is to see if the ablation improves outcomes and quality of life compared to standard medications.
This study investigates whether a catheter ablation procedure can improve wellbeing and reduce the risk of serious events for people 80 and older with symptomatic atrial fibrillation. The goal is to see if this treatment offers better outcomes than standard care in this age group.
This study is a registry that collects real-world information on people with atrial fibrillation to learn more about their health and treatment. It's for adults aged 18 to 64 with a low stroke risk score who can come for checkups.
This trial tests whether early catheter ablation (a procedure to fix irregular heartbeats) helps people who have both heart failure and atrial fibrillation. It looks at how this treatment affects your heart function and quality of life.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.